LUNG CANCER STAGE III
Clinical trials for LUNG CANCER STAGE III explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER STAGE III trials appear
Sign up with your email to follow new studies for LUNG CANCER STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo may make inoperable lung cancer removable
Disease control Recruiting nowThis study tests whether a combination of drugs given before surgery can shrink advanced stage III lung cancer enough to allow surgical removal. About 36 adults with unresectable non-small cell lung cancer will receive the treatment. The main goal is to see how many patients can …
Matched conditions: LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Could an arthritis drug boost chemo for lung cancer?
Disease control Recruiting nowThis study tests whether adding certolizumab (an anti-inflammatory drug) to standard chemotherapy before surgery can shrink stage II-III lung cancers more than chemo alone. About 60 adults with operable lung cancer will receive the combination, then have surgery to remove any rem…
Matched conditions: LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New hope for hard-to-treat lung cancer: targeted therapy before surgery shows promise
Disease control Recruiting nowThis study tests whether giving targeted drugs before surgery can shrink tumors enough to remove them in people with stage III lung cancer that has rare gene mutations. About 120 participants will receive a treatment chosen based on their tumor's genetic profile. The main goal is…
Matched conditions: LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 11, 2026 20:51 UTC